Genmab A (GMAB) Inventory (2023 - 2026)

Genmab A has reported Inventory for 4 years, with the latest figure at $21.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 800.0% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at $21.0 million (up 800.0% YoY), and the FY2025 full-year result was $18.0 million, up 100.0% from the prior year.
• Inventory for Q1 2026 stood at $21.0 million, up from $18.0 million in the prior quarter.
• The five-year high for Inventory was $21.0 million in Q1 2026, with the low at -$7.0 million in Q1 2024.
• Historically, Inventory has averaged $3.8 million across 4 years, with a median of $500000.0 in 2024.
• Annual changes were most pronounced in 2025 — Inventory sank 233.33% — and 2026, when it surged 800.0%.
• Genmab A's Inventory stood at $8.0 million in 2023, then increased by 12.5% to $9.0 million in 2024, then surged by 100.0% to $18.0 million in 2025, then rose by 16.67% to $21.0 million in 2026.
• The last three Inventory figures came in at $21.0 million (Q1 2026), $18.0 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.